Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Immunitybio Inc (IBRX)
Immunitybio Inc (IBRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Immunitybio Inc 3530 JOHN HOPKINS COURT SAN DIEGO CA 92121 USA

https://immunitybio.com P: 844-696-5235

Description:

ImmunityBio Inc. is a late-clinical-stage immunotherapy company developing therapies which drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems. ImmunityBio Inc., formerly known as NantKwest Inc., is based in CULVER CITY, Calif.

Key Statistics

Overview:

Market Capitalization, $K 3,144,891
Enterprise Value, $K 3,281,521
Shares Outstanding, K 667,705
Annual Sales, $ 240 K
Annual Net Income, $ -416,570 K
Last Quarter Sales, $ 80 K
Last Quarter Net Income, $ -95,580 K
EBIT, $ -361,090 K
EBITDA, $ -325,230 K
60-Month Beta 1.24
% of Insider Shareholders 83.40%
% of Institutional Shareholders 8.60%
Float, K 110,839
% Float 16.60%
Short Volume Ratio 0.49

Growth:

1-Year Return 107.49%
3-Year Return -82.43%
5-Year Return 306.03%
5-Year Revenue Growth 380.00%
5-Year Earnings Growth 100.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.19 on 11/08/23
Latest Earnings Date 03/06/24
Earnings Per Share ttm -0.74
EPS Growth vs. Prev Qtr 32.14%
EPS Growth vs. Prev Year 32.14%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

IBRX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % -123.50%
Profit Margin % -173,570.84%
Debt/Equity -1.57
Price/Sales 3,737.65
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -0.62
Interest Coverage -5.57
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar